Merck (MRK) Rises Higher Than Market: Key Facts [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
The stock's performance was ahead of the S&P 500's daily gain of 0.11%. Elsewhere, the Dow saw an upswing of 0.12%, while the tech-heavy Nasdaq depreciated by 0.12%. The pharmaceutical company's shares have seen an increase of 2.78% over the last month, surpassing the Medical sector's gain of 0.46% and falling behind the S&P 500's gain of 3.55%. The upcoming earnings release of Merck will be of great interest to investors. The company's earnings report is expected on April 25, 2024. The company is predicted to post an EPS of $2.12, indicating a 51.43% growth compared to the equivalent quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $15.32 billion, indicating a 5.75% increase compared to the same quarter of the previous year. For the annual period, the Zacks Consensus Estimates anticipate earnings of $8.59 per share and a revenue of $64.05 billion, signifying shifts of +468.87% and +6.54%, respectively, from the last year. It's also import
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Truist Financial Co. from $142.00 to $143.00. They now have a "buy" rating on the stock.MarketBeat
- Merck (MRK) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook [Yahoo! Finance]Yahoo! Finance
- Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales [Yahoo! Finance]Yahoo! Finance
- Merck (MRK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 4/25/24 - Beat
MRK
Sec Filings
- 4/25/24 - Form 8-K
- 4/11/24 - Form ARS
- 4/11/24 - Form DEFA14A
- MRK's page on the SEC website